Effects of ‘doctor shopping’ behaviour on prescription of addictive drugs in Sweden
Permanent lenke
https://hdl.handle.net/10037/26070Dato
2022-01-22Type
Journal articleTidsskriftartikkel
Peer reviewed
Sammendrag
Free choice of health care providers is aimed to improve the quality of health care by increasing both access to it
and the competition between providers. However, it may also give patients possibilities for doctor shopping (DS)
behaviour, i.e., visiting different providers to receive illicit drug prescriptions. Abuse of prescribed addictive
drugs is a growing problem worldwide and is associated with increased mortality, lower quality of life and other
problems on both the individual and societal level. We study DS behaviour for three categories of addictive drugs
– opioid painkillers, benzodiazepine anxiolytics, and z-hypnotic sleeping drugs, in the outpatient care sector in
V¨
asterbotten County, Sweden. Our dataset contains all drug prescriptions purchased by the residents of
V¨
asterbotten in the period from January 2014 to April 2016 (approximately 160,000 observations). To identify
signs of addictive prescription drugs abuse by DS, we analyse overlapping prescriptions. We use ‘Defined Daily
Doses’ (DDDs), which is the average treatment dose of a specific drug per day for adults, as a proxy for the
treatment duration. To control for medically legitimate overlaps, we compare overlapping prescriptions within a
clinic with overlapping prescriptions between different clinics. Our empirical results suggest that there is a
significant and positive relationship between the number of overlapping doses and the number of unique providers in the overlap. More specifically, we find that visiting different providers on average gives patients up to
three additional DDDs per day. This is three times higher than the standard treatment dose. We discuss policy
implications in the concluding discussion.
Forlag
ElsevierSitering
Zykova, Mannberg, Myrland. Effects of ‘doctor shopping’ behaviour on prescription of addictive drugs in Sweden. Social Science and Medicine. 2022;296Metadata
Vis full innførselSamlinger
Copyright 2022 The Author(s)